Matinas Biopharma Holdings (MTNB) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

MTNB is expected to report earnings to rise 25.00% to -2 cents per share on November 06

Matinas Biopharma Holdings MTNB Stock Earnings Reports

Q3'24

Est.

$-0.03

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.03

Q4'23

Beat

by $0.01

Q3'23

Est.

$-0.03

The last earnings report on August 14 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 63.04K shares outstanding, the current market capitalization sits at 17.91M.

View a ticker or compare two or three

Compare

MTNB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MTNB
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1545 Route 206 South

Phone

+1 908 484-8805

Employees

Web

https://www.matinasbiopharma.com